公开(公告)号：WO2015053789A1

公开(公告)日：2015-04-16

申请号：PCT/US2013/064659

申请日：2013-10-11

Applicant: ABBOTT LABORATORIES

Inventor： DEWILLE, Normanella ,  CABRERA, Ricardo Rueda ,  MARRIAGE, Barbara ,  SHERRY, Christina ,  WEARLY, Douglas ,  PEDROSA, Jose Maria Lopez ,  BLUMBERG, Rachel ,  MAZER, Terrence

IPC: A23L1/30 ,  A23L1/305 ,  A23L1/308 ,  A23L2/52 ,  A23L2/66 ,  A23L1/09 ,  A23L1/29

CPC classification number: A23L1/296 ,  A23L2/52 ,  A23L2/66 ,  A23L5/00 ,  A23L29/30 ,  A23L33/115 ,  A23L33/12 ,  A23L33/125 ,  A23L33/17 ,  A23L33/21 ,  A23L33/40 ,  A23V2002/00

Abstract: The present disclosure is directed to a nutritional powder, a translucent reconstitutable beverage formed therefrom, and methods relating thereto. The nutritional powder and beverage are adapted to include the proper balance of proteins, lipids, carbohydrates, vitamins and minerals appropriate for a pregnant woman. The nutritional compositions further stem the glycemic response and improve glycemia and insulinemia during gestational and lactating periods for preventing or reduce the incidence of glucose intolerance later in life.

Abstract translation: 本公开涉及营养粉末，由其形成的半透明可再生饮料以及与其相关的方法。 营养粉末和饮料适于包括适合于孕妇的蛋白质，脂质，碳水化合物，维生素和矿物质的适当平衡。 营养组合物进一步阻止血糖反应，并改善妊娠期和哺乳期期间的血糖和胰岛素血症，以预防或减少生命后期葡萄糖不耐受的发生。

公开(公告)号：WO2013180747A2

公开(公告)日：2013-12-05

申请号：PCT/US2012/067712

申请日：2012-12-04

Applicant: ABBOTT LABORATORIES

Inventor： MARRIAGE, Barbara, J. ,  CLINGER, Christine, L. ,  SHERRY, Christina

IPC: A61K31/7076

CPC classification number: A61K31/708 ,  A23L5/44 ,  A23L33/13 ,  A23L33/155 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K31/01 ,  A61K31/015 ,  A61K31/047 ,  A61K31/7068 ,  A61K31/7076 ,  A23V2200/328 ,  A23V2250/211

Abstract: The present disclosure is directed to reduced calorie infant formulas, and in particular, reduced calorie infant formulas that have at least one nucleotide and/or at least one carotenoid for reducing inflammation-related diseases later in life. Particularly, the reduced calorie infant formulas reduce the risk of obesity later in life.

Abstract translation: 本公开涉及减少热量的婴儿配方，特别是具有至少一种核苷酸和/或至少一种类胡萝卜素的减少热量的婴儿配方，以减少生命中以后的炎症相关疾病。 特别地，减少热量的婴儿配方可以降低生命后期的肥胖风险。

公开(公告)号：WO2014160286A1

公开(公告)日：2014-10-02

申请号：PCT/US2014/026239

申请日：2014-03-13

Applicant: ABBOTT LABORATORIES

Inventor： LAI, Chron-Si ,  BLOCH, Tama ,  SHERRY, Christina ,  GONZALEZ, Maria Ramirez ,  KUCHAN, Matthew ,  KATZ, Gary ,  DELGADO, Elena, Oliveros ,  SANTOS, Angela

IPC: A23L1/30 ,  A23L1/303 ,  A23L1/29 ,  A61K31/202 ,  A61K31/355

CPC classification number: A61K31/685 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A23L33/13 ,  A23L33/15 ,  A23L33/155 ,  A23L33/40 ,  A23V2002/00 ,  A61K9/48 ,  A61K9/4808 ,  A61K31/015 ,  A61K31/045 ,  A61K31/047 ,  A61K31/065 ,  A61K31/202 ,  A61K31/355 ,  A61K31/593 ,  A61K2300/00

Abstract: Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.

Abstract translation: 公开了孕妇和哺乳期妇女的产前和哺乳期补品，其中包括RRR-α-生育酚，二十二碳六烯酸（DHA），反式叶黄素，磷脂以及除RRR-α-生育酚之外的至少一种核受体活化配体的组合， 生育酚，DHA和反式叶黄素。 补充剂可以增强胎儿或母乳喂养新生儿的中枢神经系统发育。

公开(公告)号：WO2015161153A1

公开(公告)日：2015-10-22

申请号：PCT/US2015/026297

申请日：2015-04-17

Applicant: ABBOTT LABORATORIES

Inventor： SHERRY, Christina ,  LAI, Chron-Si ,  MARRIAGE, Barbara ,  KUCHAN, Matthew

IPC: A61K31/355

CPC classification number: A61K31/355

Abstract: Methods for increasing RRR-alpha-tocopherol in the tissues of a pre-pregnant, pregnant, or lactating woman are disclosed. The woman is administered a nutritional supplement containing a blend of alpha tocopherols comprising RRR-alpha-tocopherol and non-RRR-alpha-tocopherol. The blend of alpha tocopherols has a weight ratio of RRR-alpha-tocopherol to non-RRR-alpha-tocopherol between about 0.5:1 to about 1,000:1. Methods for increasing RRR-alpha-tocopherol for a fetus are also disclosed, where the fetus receives increased RRR-alpha-tocopherol from a pregnant woman who is administered a prenatal nutritional supplement containing a blend of alpha-tocopherols with a weight ratio of RRR-alpha-tocopherol to non-RRR-alpha-tocopherol between about 0.5:1 to about 1,000:1. Methods for increasing RRR-alpha-tocopherol for a breast milk-fed infant are also disclosed, where the infant receives increased RRR-alpha-tocopherol from the breast milk of a pregnant woman who is administered a postpartum nutritional supplement containing a blend of alpha-tocopherols with a weight ratio of RRR-alpha-tocopherol to non-RRR-alpha-tocopherol between about 0.5:1 to about 1,000:1. These methods provide the woman's body with increased RRR-alpha-tocopherol, which is then preferentially available to her developing fetus or nursing infant.

Abstract translation: 公开了在孕前，怀孕或哺乳期妇女组织中增加RRR-α-生育酚的方法。 施用含有包含RRR-α-生育酚和非RRR-α-生育酚的α-生育酚混合物的营养补充剂的妇女。 α-生育酚的共混物具有约0.5:1至约1,000:1之间的RRR-α-生育酚与非RRR-α-生育酚的重量比。 还公开了用于增加胎儿的RRR-α-生育酚的方法，其中胎儿从孕妇接受增加的RRR-α-生育酚，该孕妇给予含有α-生育酚混合物的产前营养补充剂，其中重量比为RRR- α-生育酚与非RRR-α-生育酚之间约0.5:1至约1,000:1之间。 还公开了用于增加母乳喂养的婴儿的RRR-α-生育酚的方法，其中婴儿从孕妇的母乳中接受增加的RRR-α-生育酚，该孕妇给予含有α-乳糖的混合物的产后营养补充剂， 生育酚与RRR-α-生育酚与非RRR-α-生育酚的重量比在约0.5:1至约1,000:1之间。 这些方法为女性身体提供了增加的RRR-α-生育酚，然后优先使用她的发育中的胎儿或哺乳婴儿。